Two-Pronged attack on high cholesterol shows promise
NCT ID NCT05559606
Summary
This study observed nearly 1,840 real-world patients with high cholesterol who were prescribed a single pill containing two medications (atorvastatin and ezetimibe). The goal was to see how well and how safely this combination treatment worked over 24 weeks to lower 'bad' cholesterol (LDL-C) to target levels. Researchers collected data on cholesterol levels and side effects to understand the treatment's real-world performance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.